WeiShi

WeiShi Biological is a Chinese biotechnology company specializing in the development and manufacture of high-quality reagents and diagnostic solutions for the life sciences industry. The company focuses on providing critical raw materials, including recombinant proteins and antibodies, used in the production of in vitro diagnostic (IVD) kits. WeiShi gained significant prominence for its rapid development of antigens and antibodies used in COVID-19 testing during the global pandemic. Their product portfolio supports research and clinical diagnostics across various infectious diseases and chronic conditions. By maintaining rigorous quality control standards, WeiShi serves as a key supplier to both domestic and international diagnostic kit manufacturers.